Ken Griffin’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$536K Sell
235,139
-1,386,872
-86% -$3.19M ﹤0.01% 9131
2025
Q4
$4.54M Sell
1,622,011
-271,766
-14% -$971K ﹤0.01% 4434
2025
Q3
$9.09M Buy
1,893,777
+1,589,729
+523% +$10.1M ﹤0.01% 3415
2025
Q2
$2.77M Sell
304,048
-7,489
-2% -$55.2K ﹤0.01% 5113
2025
Q1
$2.81M Buy
+311,537
New +$3.29M ﹤0.01% 4884
2024
Q4
Sell
-1,313,398
Closed -$17.5M 15126
2024
Q3
$20.6M Buy
+1,313,398
New +$19.9M ﹤0.01% 2021
2024
Q1
Sell
-79,190
Closed -$1.76M 15232
2023
Q4
$1.53M Sell
79,190
-5,197
-6% -$94.1K ﹤0.01% 5855
2023
Q3
$1.36M Sell
84,387
-78,899
-48% -$1.4M ﹤0.01% 5959
2023
Q2
$3.11M Sell
163,286
-111,728
-41% -$1.99M ﹤0.01% 4402
2023
Q1
$4M Buy
275,014
+273,848
+23,486% +$4.91M ﹤0.01% 4162
2022
Q4
$22.8K Sell
1,166
-329,667
-100% -$6.43M ﹤0.01% 13039
2022
Q3
$7.97M Buy
330,833
+127,781
+63% +$3.94M ﹤0.01% 3090
2022
Q2
$6.39M Buy
203,052
+162,435
+400% +$5.88M ﹤0.01% 3364
2022
Q1
$1.79M Sell
40,617
-1,282,388
-97% -$55.1M ﹤0.01% 6331
2021
Q4
$57.6M Sell
1,323,005
-208,759
-14% -$8.18M 0.01% 1059
2021
Q3
$47.9M Buy
1,531,764
+1,355,349
+768% +$53.3M 0.01% 1165
2021
Q2
$7.47M Sell
176,415
-290,267
-62% -$11.3M ﹤0.01% 3618
2021
Q1
$17.5M Sell
466,682
-1,082,737
-70% -$33.9M ﹤0.01% 2137
2020
Q4
$41.9M Buy
1,549,419
+933,759
+152% +$24M 0.01% 1095
2020
Q3
$15.5M Buy
615,660
+546,449
+790% +$7.97M ﹤0.01% 1802
2020
Q2
$528K Buy
+69,211
New +$507K ﹤0.01% 6975
2019
Q4
Sell
-182,415
Closed -$1.17M 9557
2019
Q3
$1.06M Buy
182,415
+143,814
+373% +$645K ﹤0.01% 5506
2019
Q2
$124K Sell
38,601
-891,536
-96% -$3.04M ﹤0.01% 8446
2019
Q1
$3.81M Buy
930,137
+435,522
+88% +$2.75M ﹤0.01% 3381
2018
Q4
$3.13M Buy
494,615
+33,437
+7% +$347K ﹤0.01% 3453
2018
Q3
$7.62M Sell
461,178
-178,475
-28% -$3.03M ﹤0.01% 2463
2018
Q2
$10.7M Sell
639,653
-219,040
-26% -$3.55M 0.01% 1867
2018
Q1
$13.4M Buy
858,693
+86,426
+11% +$1.54M 0.01% 1472
2017
Q4
$14.6M Buy
772,267
+700,585
+977% +$15.5M 0.01% 1390
2017
Q3
$2.09M Sell
71,682
-111,498
-61% -$3.29M ﹤0.01% 3356
2017
Q2
$5.9M Buy
183,180
+163,387
+825% +$5.36M 0.01% 1943
2017
Q1
$685K Sell
19,793
-7,445
-27% -$266K ﹤0.01% 4534
2016
Q4
$961K Sell
27,238
-254,419
-90% -$8.6M ﹤0.01% 3908
2016
Q3
$9.78M Sell
281,657
-33,118
-11% -$1.16M 0.01% 1376
2016
Q2
$11.8M Buy
314,775
+79,098
+34% +$2.97M 0.01% 1117
2016
Q1
$9.53M Sell
235,677
-107,587
-31% -$4.01M 0.01% 1235
2015
Q4
$12.3M Buy
343,264
+271,374
+377% +$9.82M 0.01% 1127
2015
Q3
$2.3M Sell
71,890
-111,556
-61% -$3.8M ﹤0.01% 2769
2015
Q2
$6.24M Sell
183,446
-169,886
-48% -$5.72M 0.01% 1864
2015
Q1
$12M Sell
353,332
-166,299
-32% -$5.79M 0.01% 1314
2014
Q4
$18.2M Sell
519,631
-64,667
-11% -$2.18M 0.02% 1005
2014
Q3
$19.1M Buy
584,298
+24,425
+4% +$831K 0.02% 933
2014
Q2
$19M Buy
559,873
+144,816
+35% +$4.96M 0.02% 838
2014
Q1
$14.5M Buy
415,057
+93,013
+29% +$3.28M 0.02% 1041
2013
Q4
$11.8M Buy
322,044
+32,108
+11% +$1.18M 0.02% 1108
2013
Q3
$10M Sell
289,936
-4,231
-1% -$148K 0.02% 1100
2013
Q2
$9.95M Buy
+294,167
New +$9.76M 0.02% 1070

Other funds holding ACH

Ken Griffin's ACH Position: Q1 2026 in Review

Ken Griffin reduced its Accendra Health (ACH) stake by 86% in Q1 2026, selling an estimated $3.19M and leaving 235,139 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #9131.

Ken Griffin first reported a position in ACH in Q2 2013 and has held it in 47 quarters since. The position peaked at $57.6M in Q4 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Ken Griffin held 235,139 shares of Accendra Health worth $536K as of Q1 2026.
  • Ken Griffin sold 1,386,872 Accendra Health shares in Q1 2026, an estimated $3.19M.
  • Accendra Health made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #9131 holding.
  • Ken Griffin first reported a position in Accendra Health in Q2 2013 and has held it in 47 quarters since.
  • Ken Griffin's Accendra Health position peaked at $57.6M in Q4 2021.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.